The results showed that the tumor group had considerably larger proportions of most immune cells than the control groups, with the exception of some immune cells such as CD56 dim natural killer cells in BRCA,LUAD, and STAD (Fig. 7C). Here, NCAM1 is linked to invasive breast carcinoma.